ArticleMaterials (Basel, Switzerland)2026
Flame-Retardant ABS Composites for 3D Printing: Synergistic Effects of Phosphorus-Based Additives.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
In this study, the effects of the type and content of phosphorus-based flame retardants, namely melamine polyphosphate (MPP) and aluminum diethylphosphinate (AlDPi), as well as their hybrid systems (MPP:AlDPi ratios of 1:1, 1:3, and 3:1), on the fire performance of acrylonitrile-butadiene-styrene (ABS) composites were investigated. The obtained results indicate that the synergistic action of MPP and AlDPi, including simultaneous inhibition of combustion in the gas phase and action in the condensed phase, leads to a significant improvement in the fire-retardant properties of ABS composites. For unmodified ABS, the peak Heat Release Rate (pHRR) and Total Heat Released (THR) values were 808.7 kW/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.